Bead-GPS Proteomic Screening via MALDI-TOF MS Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current proteomic arrays face limitations in scalability, sensitivity, and cost due to labor-intensive production methods and low replicate numbers, making them inefficient for comprehensive protein expression profiling and biomarker discovery, especially in autoimmune diseases and cancers.

Innovation Solution

A novel approach using Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for bead-based global proteomic screening (Bead-GPS) with photocleavable mass tags on random protein-bead arrays, enabling rapid identification of protein interactions and autoantigen discovery by decoding beads with MALDI-TOF MS imaging and fluorescence scanning.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If labor-intensive production methods are used for proteomic arrays, then manufacturing precision can be maintained, but productivity is reduced and costs increase

Engineering Contradiction:
Improveproteomic array production precisionVSAvoidproteomic screening throughput
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent replaces mechanical printing methods with microfluidic-based droplet generation and deposition systems. This substitution enables automated, high-throughput production of proteomic arrays while maintaining precision through controlled fluid dynamics and digital micromirror device (DMD) guidance, eliminating labor-intensive manual operations.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the production parameters by using picoliter-scale droplets instead of traditional printing methods. This parameter change enables thousands of features to be generated in parallel on a single chip, dramatically increasing productivity while maintaining manufacturing precision through precise control of droplet formation, deposition, and drying conditions.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If replicate numbers are increased for comprehensive protein expression profiling, then measurement precision is improved, but device complexity and cost increase

Engineering Contradiction:
Improveprotein expression profiling accuracyVSAvoidarray structure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the proteomic array into thousands of independent picoliter-scale droplet features, each containing replicate measurements. This segmentation allows high replicate numbers to be achieved within a compact chip area, improving measurement precision without proportionally increasing device complexity, as the replication is achieved through spatial multiplication rather than structural complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from traditional two-dimensional array layouts to a three-dimensional utilization of space by creating densely packed droplet features with controlled spacing. This dimensional optimization allows hundreds of replicates per protein to be accommodated on a single chip without excessive complexity, as the replicates are organized in a systematic grid pattern rather than requiring complex structural arrangements.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Ease of manufacture

If traditional proteomic array methods are used, then ease of manufacture is maintained, but sensitivity and scalability are limited

Engineering Contradiction:
Improvearray production simplicityVSAvoidbiomarker detection sensitivity
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent replaces traditional mechanical printing with microfluidic droplet generation and digital micromirror device (DMD) guidance. This substitution maintains ease of manufacture through automated fluid handling and digital patterning while dramatically improving sensitivity by creating uniform, picoliter-scale features that enhance signal-to-noise ratios and enable detection of low-abundance biomarkers.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the volume parameter to picoliter-scale droplets and uses UV irradiation for controlled protein deposition. These parameter changes improve detection sensitivity by concentrating analytes in smaller volumes and enabling precise spatial control, while the overall process remains manufacturable through automated microfluidic operation and standard UV processing equipment.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If high replicate numbers are implemented, then reliability is improved, but loss of time in sample processing increases

Engineering Contradiction:
Improveproteomic screening reliabilityVSAvoidsample processing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent implements continuous processing where droplets are generated, deposited, and dried in an uninterrupted sequence. High replicate numbers are achieved through parallel processing of multiple droplets simultaneously on the chip, rather than sequential processing. This continuity maintains reliability through consistent replicate measurements while minimizing time loss by eliminating idle periods between replicate analyses.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent segments the proteomic analysis into independent droplet features that can be processed in parallel. Each droplet contains replicate measurements, and all droplets are analyzed simultaneously rather than sequentially. This segmentation enables high replicate numbers to contribute to reliability without proportionally increasing total processing time, as the replicates are evaluated concurrently through the unified MALDI-TOF MS imaging workflow.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for high-throughput, cost-effective, and sensitive proteomic screening, enabling the identification of millions of protein interactions and biomarkers, improving diagnostic sensitivity and specificity for autoimmune diseases and cancers.

Implementation Method 1

Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)

Methodology Applied
Scientific EffectMatrix Assisted Laser Desorption Ionization:

Implementation Method 2

Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)

Methodology Applied
Scientific EffectTime-of-Flight: Time of Flight

Implementation Method 3

fluorescence scanning

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12013392B2Global proteomic screening of random bead arrays using mass spectrometry imaging
Publication Date: 2024.06.18 AMBERGEN INC
  • US12013392B2 patent drawing
  • US12013392B2 patent drawing
  • US12013392B2 patent drawing

AI summary

Methods for proteomic screening on random protein-bead arrays by mass spec is described. Photocleavable mass tags are utilized to code a protein library (bait molecules) displayed on beads randomly arrayed in an array substrate. A library of probes (prey) can be mixed with the protein-bead array to query the array. Because mass spec can detect multiple mass tags, it is possible to rapidly identify all of the interactions resulting from this mixing.